Victory Pharma in deal for MiddleBrook assets; Submarine contractor may bid on Pfizer site;

 @FiercePharma: Pharma's 'aggressive' tax-avoidance tactics draw fire. Article | Follow @FiercePharma

> Victory buys bankrupt Middlebrook's assets.  News

> Mystic Seaport officials say the tourist attraction has decided not to bid on Pfizer's New London campus, but submarine contractor Electric Boat might still be interested in the 33-acre waterfront site. Report

> Members of the United Steel Workers International union Local 10-86 in Pennsylvania have voted to accept a three-year contract with Merck. Report

> Impax Laboratories got the FDA nod for its version of the Endo Pharmaceuticals' pain drug Opana. Release

> Danish biopharmaceuticals group Bavarian Nordic has begun deliveries of its Imvamune smallpox vaccine to the U.S. Strategic National Stockpile. Report

> Santarus said it appealed a U.S. district court ruling against it in a patent lawsuit versus Par Pharmaceuticals, sending shares of the specialty pharmaceutical company up 8 percent. Report

> Government efforts to raise at least $21 million by selling a 19.26 percent stake in Bosnia's top drug firm Bosnalijek failed in an offering on the Sarajevo Stock Exchange. Report

Biotech News

 @FierceBiotech: Wall Street to keep eye on Vertex data. Article |  Follow @FierceBiotech

@JohnCFierce: And speaking of hep C, the BBC does a closeup on Inhibitex's INX-189. Article | Follow @JohnCFierce

> Pharming to divest DNage, focus on Rhucin. Story

> Amgen eyes wider Dmab approval. Item

> Novo Nordisk shines among drugmakers. Report

Biotech IT News

> Pfizer mines data to find compounds for repurposing. Item

> OpenClinica gets case report form library. Story

> NCI grant targets trial design improvement. News

> Amazon answers biopharma's cloud interest. Article

> Lilly continues cloud computing efforts. Report

> Medidata, Aris combine EDC and safety systems. News

And Finally... Dartmouth College is getting $35 million to open a center it hopes will help the nation take the next big steps in healthcare reform: improving quality while lowering costs. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.